HongYua,b,KaiLua,b,andJiananWanga,b,*.Treatmentofheartfailureaftermyocardialinfarctionwithbonemarrow-derivedmesenchymalstemcells.
CardiologyPlus
《门诊》获授权转载。
aDepartmentofCardiology,SecondAffiliatedHospital,CollegeofMedicine,ZhejiangUniversity,Hangzhou,,PRChina;
bCardiovascularKeyLaboratoryofZhejiangProvince,Hangzhou,,PRChina;
*Correspondingauthors:JiananWang,MD,PhD,DepartmentofCardiology,SecondAffiliatedHospital,CollegeofMedicine,ZhejiangUniversity,Hangzhou,China.
AbstractHeartfailure(HF)aftermyocardialinfarction(MI)representsaworldwidepublichealthissuewithgraduallyincreasingincidence.HFmayeventuallyaffectallorgansandtissues,andisassociatedwithsignificantmorbidityandmortality.CurrenttherapeuticmethodstotreatHFstayatonlydelayingthediseaseprogressionwithoutrepairandregeneration.Recently,celltransplantationhasgraduallybe太原治疗白癜风医院北京治疗白癜风哪间医院最好
转载请注明地址:http://www.dkhgq.com/zcmbhl/1239.html